(Q56994324)

2

0 references

Anna Chiara Dall'Aglio

3

0 references

Georgios Pappas

4

0 references

Francesco B Bianchi

5

0 references

Daniela Zauli

Rheumatology International

6

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

0 references

volume

28

0 references

issue

1

0 references

page(s)

47-9

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00296-007-0379-5

0 references

cites work

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

1 reference

12 December 2020

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

12 December 2020

Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report

1 reference

12 December 2020

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

1 reference

12 December 2020

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.

1 reference

12 December 2020

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies

1 reference

12 December 2020

Autoimmunity and anti-TNF-alpha agents

1 reference

12 December 2020

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

1 reference

12 December 2020

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha

1 reference

12 December 2020